DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced completion of CE marking (market approval) in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD ...
Baxter International Inc. BAX recently announced that it has received CE marking approval in Europe for HOMECHOICE CLARIA – its automated peritoneal dialysis (APD) system integrated with the ...
With one in four APD patients globally benefitting from Baxter’s two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug ...
Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results